Can the addition of radiolabeled treatments improve outcomes in advanced metastatic disease?
Tuesday, November 13, 2012 - 22:30
in Health & Medicine
Radiolabeled agents are powerful tools for targeting and killing cancer cells and may help improve outcomes and lengthen survival times of patients with advanced disease that has spread beyond the initial tumor site. Effective therapy for metastatic cancer requires acombination of treatments, and the benefits of adding radionuclide therapy are explored in three studies.